PepGen Statistics
Total Valuation
PepGen has a market cap or net worth of $116.90 million. The enterprise value is $462,281.
| Market Cap | 116.90M |
| Enterprise Value | 462,281 |
Important Dates
The next estimated earnings date is Thursday, August 6, 2026, before market open.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
PepGen has 69.17 million shares outstanding. The number of shares has increased by 57.50% in one year.
| Current Share Class | 69.17M |
| Shares Outstanding | 69.17M |
| Shares Change (YoY) | +57.50% |
| Shares Change (QoQ) | +0.44% |
| Owned by Insiders (%) | 0.21% |
| Owned by Institutions (%) | 41.99% |
| Float | 36.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.87 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.98, with a Debt / Equity ratio of 0.12.
| Current Ratio | 14.98 |
| Quick Ratio | 14.76 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.40% and return on invested capital (ROIC) is -38.96%.
| Return on Equity (ROE) | -68.40% |
| Return on Assets (ROA) | -35.79% |
| Return on Invested Capital (ROIC) | -38.96% |
| Return on Capital Employed (ROCE) | -55.14% |
| Weighted Average Cost of Capital (WACC) | 12.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.31M |
| Employee Count | 59 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, PepGen has paid $64,000 in taxes.
| Income Tax | 64,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +23.02% in the last 52 weeks. The beta is 1.93, so PepGen's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +23.02% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 53.90 |
| Average Volume (20 Days) | 653,822 |
Short Selling Information
The latest short interest is 3.75 million, so 5.41% of the outstanding shares have been sold short.
| Short Interest | 3.75M |
| Short Previous Month | 3.46M |
| Short % of Shares Out | 5.41% |
| Short % of Float | 10.39% |
| Short Ratio (days to cover) | 4.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.23M |
| Pretax Income | -77.15M |
| Net Income | -77.22M |
| EBITDA | -79.91M |
| EBIT | -81.23M |
| Earnings Per Share (EPS) | -$1.50 |
Balance Sheet
The company has $132.30 million in cash and $16.56 million in debt, with a net cash position of $115.74 million or $1.67 per share.
| Cash & Cash Equivalents | 132.30M |
| Total Debt | 16.56M |
| Net Cash | 115.74M |
| Net Cash Per Share | $1.67 |
| Equity (Book Value) | 133.98M |
| Book Value Per Share | 1.94 |
| Working Capital | 125.31M |
Cash Flow
In the last 12 months, operating cash flow was -$77.13 million and capital expenditures -$139,000, giving a free cash flow of -$77.27 million.
| Operating Cash Flow | -77.13M |
| Capital Expenditures | -139,000 |
| Depreciation & Amortization | 1.33M |
| Net Borrowing | n/a |
| Free Cash Flow | -77.27M |
| FCF Per Share | -$1.12 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PepGen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -57.50% |
| Shareholder Yield | -57.50% |
| Earnings Yield | -66.45% |
| FCF Yield | -66.49% |
Analyst Forecast
The average price target for PepGen is $10.25, which is 506.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.25 |
| Price Target Difference | 506.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |